title: Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
authors.affiliation: Faculté de Médecine and Clinique Dermatologique, Université de Strasbourg, Strasbourg, France.
authors.forename: Virginie
authors.initials: V
authors.lastname: Lutz
authors.forename: Dan
authors.initials: D
authors.lastname: Lipsker
mesh_terms: D017255:Acitretin / Q000009:adverse effects / Q000627:therapeutic use*; D000169:Acrodermatitis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination; D005260:Female; D011345:Fenofibrate / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy; D007279:Injections, Subcutaneous; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects / Q000627:therapeutic use*; D007641:Keratolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D007641:Keratolytic Agents; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D017255:Acitretin; D011345:Fenofibrate